3lzv: Difference between revisions
From Proteopedia
Jump to navigationJump to search
New page: '''Unreleased structure''' The entry 3lzv is ON HOLD Authors: Schiffer, C.A., Kolli, M. Description: Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Daruna... |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Seed}} | |||
[[Image:3lzv.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3lzv", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3lzv| PDB=3lzv | SCENE= }} | |||
===Structure of Nelfinavir-resistant HIV-1 protease (D30N/N88D) in complex with Darunavir.=== | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | <!-- | ||
The line below this paragraph, {{ABSTRACT_PUBMED_20660190}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 20660190 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_20660190}} | |||
==About this Structure== | |||
3LZV is a 2 chains structure with sequences from [http://en.wikipedia.org/wiki/Hiv-1_m:b_arv2/sf2 Hiv-1 m:b_arv2/sf2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3LZV OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:20660190</ref><references group="xtra"/> | |||
[[Category: HIV-1 retropepsin]] | |||
[[Category: Hiv-1 m:b_arv2/sf2]] | |||
[[Category: Kolli, M.]] | |||
[[Category: Schiffer, C A.]] | |||
[[Category: Hiv-1 protease]] | |||
[[Category: Hydrolase]] | |||
[[Category: Resistance]] | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 11 23:56:28 2010'' | |||
Revision as of 19:49, 11 August 2010
Template:ABSTRACT PUBMED 20660190
About this Structure
3LZV is a 2 chains structure with sequences from Hiv-1 m:b_arv2/sf2. Full crystallographic information is available from OCA.
Reference
- Bandaranayake RM, Kolli M, King NM, Nalivaika E, Heroux A, Kakizawa J, Sugiura W, Schiffer CA. The Effect of Clade Specific Sequence Polymorphisms on HIV-1 Protease Activity and Inhibitor Resistance Pathways. J Virol. 2010 Jul 21. PMID:20660190 doi:10.1128/JVI.00505-10
Page seeded by OCA on Wed Aug 11 23:56:28 2010
